Bateman, L., Rao, P., Jones, T. H., & Kelly, D. M. (2020). SAT-049 Testosterone Therapy Reduces Inflammatory Activation of Human Monocytes in Hypogonadal Type-2 Diabetic Men as a Potential Mechanism to Improve Atherosclerosis. J Endocr Soc.
シカゴスタイル引用形Bateman, Lauren, Preethi Rao, Thomas Hugh Jones, , Daniel Marcus Kelly. "SAT-049 Testosterone Therapy Reduces Inflammatory Activation of Human Monocytes in Hypogonadal Type-2 Diabetic Men As a Potential Mechanism to Improve Atherosclerosis." J Endocr Soc 2020.
MLA引用形式Bateman, Lauren, Preethi Rao, Thomas Hugh Jones, , Daniel Marcus Kelly. "SAT-049 Testosterone Therapy Reduces Inflammatory Activation of Human Monocytes in Hypogonadal Type-2 Diabetic Men As a Potential Mechanism to Improve Atherosclerosis." J Endocr Soc 2020.